Clinical effect of Fuzheng Huayu tablets combined with entecavir in the treatment of chronic hepatitis B liver fibrosis

Clinical effect of Fuzheng Huayu tablets combined with entecavir in the treatment of chronic hepatitis B liver fibrosis

ObjectiveTo investigate the efficacy and safety of Fuzheng Huayu tablets (FZHY) combined with entecavir (ETV) in the treatment of chronic hepatitis B (CHB) liver fibrosis. MethodsA total of 52 patients with CHB liver fibrosis with an Ishak stage of ≥F3 who were treated in Ruijin Hospital, Shanghai J...

Full description

Bibliographic Details
Main Author:	GU Hongtu
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2021-02-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.02.013

Similar Items

Effect of entecavir combined with Fuzheng Huayu capsules on inflammatory factors and fibrosis markers in patients with compensated chronic hepatitis B-related cirrhosis
by: WANG He, et al.
Published: (2016-09-01)

Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats
by: Tao Yang, et al.
Published: (2020-01-01)

Therapeutic effect of telbivudine combined with Fuzheng Huayu tablets in treatment of liver fibrosis in chronic hepatitis B: a report of 60 cases
by: DONG Xiaoping
Published: (2013-09-01)

Effect of <it>Fuzheng Huayu </it>formula and its actions against liver fibrosis
by: Xu Lieming, et al.
Published: (2009-06-01)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
by: Mei Wu, et al.
Published: (2020-01-01)

Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis
by: Shu Dong, et al.
Published: (2015-01-01)

The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases
by: Jiamei Chen, et al.
Published: (2019-06-01)

Proteomic Analysis of the Effect of Fuzheng Huayu Recipe on Fibrotic Liver in Rats
by: Hongdong Xie, et al.
Published: (2013-01-01)

Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis
by: Qi-Long Chen, et al.
Published: (2015-01-01)

Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism
by: Qing-Ya Li, et al.
Published: (2013-01-01)

Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells
by: Qin Pan, et al.
Published: (2015-01-01)

Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis
by: Ke Shi, et al.
Published: (2020-01-01)

Effect of Compound Biejiaruangan Tablets combined with entecavir therapy on liver fibrosis process and immune response state in patients with chronic hepatitis b
by: Qin Yang, et al.
Published: (2018-05-01)

Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice
by: Jia Yan-Hong, et al.
Published: (2012-03-01)

Antifibrotic mechanism of Fuzheng Huayu prescription by regulation of the differential expression of microRNAs in mouse liver
by: WANG Qinglan, et al.
Published: (2016-03-01)

Clinical effect of Dahuang Zhechong capsules combined with entecavir in treatment of chronic hepatitis B patients with liver fibrosis
by: XIE Yongcai, et al.
Published: (2016-08-01)

A Randomized Controlled Study of Fuzheng Huayu Capsule for Prevention of Esophageal Variceal Bleeding in Patients with Liver Cirrhosis
by: Jie Gu, et al.
Published: (2013-01-01)

Effects of entecavir on inflammatory reaction, liver function and liver fibrosis in chronic hepatitis b patients
by: Qing-Qiang Wang, et al.
Published: (2018-07-01)

Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis: A Multicenter Double-Blind Randomized Controlled Trail
by: Ya-Nan Song, et al.
Published: (2013-01-01)

Effect of kushenin combined with entecavir therapy on hepatic fibrosis and immune response in patients with chronic hepatitis B
by: Rui Zhu
Published: (2018-11-01)

The components data of fuzheng huayu extracts, cordyceps sinensis mycelia polysaccharide, gypenosides and amygdalin
by: Wei Liu, et al.
Published: (2019-08-01)

Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis
by: Qilong Chen, et al.
Published: (2016-06-01)

Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial
by: Yangyi Chen, et al.
Published: (2020-09-01)

In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa
by: Hongri Xu, et al.
Published: (2020-02-01)

Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice
by: Rong-Qi Wang, et al.
Published: (2015-04-01)

Experience of entecavir therapy in chronic hepatitis B
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Entecavir for the treatment of chronic hepatitis B infection
by: J Shepherd, et al.
Published: (2009-10-01)

Clinical Efficacy and Safety of Eight Traditional Chinese Medicine Combined with Entecavir in the Treatment of Chronic Hepatitis B Liver Fibrosis in Adults: A Network Meta-Analysis
by: Tao Wang, et al.
Published: (2020-01-01)

The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability – A Network Pharmacology and Transcriptomics Approach
by: Xinrui Xing, et al.
Published: (2018-05-01)

Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis
by: Rong Wu, et al.
Published: (2019-01-01)

Efficacy of entecavir treatment for patients with chronic hepatitis B
by: XIA Shulin
Published: (2015-04-01)

Clinical effect of entecavir in treatment of chronic hepatitis B complicated by hepatic steatosis
by: WU Yanqin, et al.
Published: (2017-05-01)

Clinical efficacy of entecavir combined with adefovir in chronic hepatitis B patients with high viral load
by: ZHANG Wen
Published: (2014-11-01)

Clinical efficacy of combined treatment with entecavir and adefovir dipivoxil for lamivudine-resistant chronic hepatitis B
by: BAO Jun
Published: (2014-10-01)

Clinical utility of entecavir for chronic hepatitis B in Chinese patients
by: Wang JY
Published: (2013-12-01)

Fuzheng Huayu Recipe Prevented and Treated CCl4-Induced Mice Liver Fibrosis through Regulating Polarization and Chemotaxis of Intrahepatic Macrophages via CCL2 and CX3CL1
by: Man Zhang, et al.
Published: (2020-01-01)

Comparison of entecavir and adefovir for the treatment of chronic hepatitis B
by: Si-Hai Zhao, et al.

Safety and efficacy of entecavir for the treatment of chronic hepatitis B
by: Melissa Osborn
Published: (2011-02-01)

Adherence to entecavir for chronic hepatitis B and correlation with effectiveness
by: Vanessa Romero Díaz-Maroto, et al.
Published: (2015-11-01)

Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
by: Sang Hoon Ahn, et al.
Published: (2013-12-01)